Research Papers:
Sesquiterpene binding Gly-Leu-Ser/Lys-“co-adaptation pocket” to inhibit lung cancer cell epithelial–mesenchymal transition
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1628 views | HTML 2274 views | ?
Abstract
Xiao-Yu Ai1,*, Heng Zhang1,*, Shao-Yan Gao1,*, Yuan Qin1,2, Wei-Long Zhong1,2, Ju Gu1,2, Meng Li1,2, Kai-Liang Qiao1,2, Qin Tian1,2, Zhan-Hong Cui1,2, Jia-Huan Yang1,2, Zhun Bi1, Ting Xiao1,2, Shuang Chen2, Hui-Juan Liu2, Hong-Gang Zhou1,2, Tao Sun1,2 and Cheng Yang1,2
1State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China
2Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China
*These authors have contributed equally to this work
Correspondence to:
Cheng Yang, email: [email protected]
Tao Sun, email: [email protected]
Hong-Gang Zhou, email: [email protected]
Keywords: antitumor, EMT, co-adaptation pocket, ERK2, lung cancer
Abbreviations: SL: sesquiterpene lactones; PTL: parthenolide; EMT: epithelial–mesenchymal transition
Received: March 15, 2017 Accepted: June 20, 2017 Published: July 26, 2017
ABSTRACT
Sesquiterpene lactones (SL) have a wide range of applications in anti-tumor and anti-inflammatory therapy. However, the pharmacological mechanism of such substances is not clear. In this study, parthenolide (PTL) was used as an example to explore the anti-tumor effect of natural molecules and their common mechanism. We showed that PTL inhibited the proliferation and migration by reverse EMT via the ERK2/NF-κB/Snail pathway in vivo and in vitro. Interestingly, Multiple potential targets of PTL contain a Gly-Leu-Ser/Lys-“co-adaptation pocket”. This inspiring us analogies of PTL may also bind to these target proteins and play a similar function. Significantly, the Concept of co-adaptation pocket may help to increase the selectivity of drug research and development.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19599